# Glioblastoma Response Prediction to Apatinib

> **NCT04814329** · — · COMPLETED · sponsor: **Beijing Sanbo Brain Hospital** · enrollment: 18 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **OTHER:** genetic characteristic

## Key facts

- **NCT ID:** NCT04814329
- **Lead sponsor:** Beijing Sanbo Brain Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-22
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814329, "Glioblastoma Response Prediction to Apatinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04814329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*